NCT00058188View on ClinicalTrials.gov

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

PHASE3TerminatedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
OsteoporosisProstate Cancer
Interventions
DIETARY_SUPPLEMENT

cholecalciferol

Given orally

DRUG

calcium gluconate

Given orally

DRUG

zoledronic acid

Given IV

Trial Locations (3)

60611

Veterans Affairs Medical Center - Lakeside Chicago, Chicago

60612

John H. Stroger Hospital of Cook County, Chicago

60611-3013

Northwestern University, Chicago

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Northwestern University

OTHER